← Back to Search

Behavioral Intervention

Yogic Breathing Exercises for ALS

N/A
Recruiting
Led By Hon Yuen, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to follow multistep commands
Confirmed ALS diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months
Awards & highlights

Study Summary

This trial will test if a 6-week program of yogic breathing exercises can improve breathing, speech and emotional wellbeing for people with ALS.

Who is the study for?
This trial is for adults over 18 with ALS who can use the internet and follow instructions. They should be able to speak, have a certain level of lung function (FVC ≥70%), and not expect to live less than 6 months. They shouldn't be in another study or have severe hearing or vision problems.Check my eligibility
What is being tested?
The trial tests a virtual yogic breathing exercise program over six weeks, aiming to improve breathing, speech, and emotional well-being in people with ALS.See study design
What are the potential side effects?
Yogic breathing exercises are generally safe but may include mild discomfort like dizziness or shortness of breath. Emotional changes due to improved well-being might also occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand and follow complex instructions.
Select...
I have been diagnosed with ALS.
Select...
I am older than 18 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ALS Depression Inventory
ALS Specific Quality of Life-Revised
Forced vital capacity (FVC)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Yogic breathing exerciseExperimental Treatment1 Intervention
Participation in a 6 weekly virtual yogic breathing exercise training with 1-3 sessions per week.
Group II: Waitlist controlActive Control1 Intervention
Participation in usual daily activities

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,432 Total Patients Enrolled
2 Trials studying Amyotrophic Lateral Sclerosis
40,160 Patients Enrolled for Amyotrophic Lateral Sclerosis
Hon Yuen, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
2 Previous Clinical Trials
120 Total Patients Enrolled

Media Library

Yogic Breathing Exercise (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05979688 — N/A
Amyotrophic Lateral Sclerosis Research Study Groups: Yogic breathing exercise, Waitlist control
Amyotrophic Lateral Sclerosis Clinical Trial 2023: Yogic Breathing Exercise Highlights & Side Effects. Trial Name: NCT05979688 — N/A
Yogic Breathing Exercise (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05979688 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the study accommodate elderly participants over 85 years of age?

"This medical study is seeking applicants between the ages of 18 and 90. In addition, 46 trials are available for minors whereas 404 studies focus on senior patients."

Answered by AI

Do I qualify to participate in this medical trial?

"To be eligible to join this clinical trial, applicants must have amyotrophic lateral sclerosis and should fall within the 18-90 year age range. 30 participants will be admitted in total."

Answered by AI

Are there any open slots remaining for participation in this investigation?

"Accurate. It appears that clinicaltrials.gov does not have this trial actively seeking participants, as it was first posted on September 1st 2023 and last edited on July 29th 2023. Though the study is currently suspended, 540 other trials are avidly searching for subjects at present."

Answered by AI

Does the FDA recognize Yogic breathing exercise as an accepted form of therapy?

"Based on the Phase 2 trial data, we have assessed Yogic breathing exercise to be moderately safe with a score of two. Nevertheless, no efficacy has been confirmed as of yet."

Answered by AI
~20 spots leftby Aug 2025